Cyclooxygenase-2 in lung cancer.
Dubinett
Steven M
SM
Lung Cancer Research Program, UCLA Jonsson Comprehensive Cancer Center, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, Calif., USA. sdubinett@mednet.ucla.edu
Sharma
Sherven
S
Huang
Min
M
Dohadwala
Mariam
M
Pold
Mehis
M
Mao
Jenny T
JT
D000818:Animals; D000938:Antigen-Presenting Cells / Q000502:physiology; D017209:Apoptosis; D002289:Carcinoma, Non-Small-Cell Lung / Q000517:prevention & control; D017326:Clinical Trials, Phase III as Topic; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D016207:Cytokines / Q000096:biosynthesis; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000502:physiology*; D008175:Lung Neoplasms / Q000209:etiology* / Q000276:immunology / Q000517:prevention & control; D008565:Membrane Proteins; D009361:Neoplasm Invasiveness; D009389:Neovascularization, Pathologic / Q000209:etiology; D011451:Prostaglandin-Endoperoxide Synthases / Q000502:physiology*
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D016207:Cytokines; D007527:Isoenzymes; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases